Landmark ATOMIC trial shows combining immunotherapy and chemo improves outcomes for colon cancer patients with mismatch-repair deficiency
Landmark ATOMIC trial shows combining immunotherapy and chemo improves outcomes for colon cancer patients with mismatch-repair deficiency
Landmark ASCO results and advances in liquid biopsy-driven treatment switching spotlight innovation in cancer research and personalized medicine.
Triple-drug combination extending life for women with aggressive HR+/HER2− breast cancer
Results from the Sunrise-1 trial suggest a new option for patients with second-line papillary non-muscle invasive bladder cancer
In late May 2025 a major funding round highlights how investors are backing clinical-stage pipelines together with AI …
: Two radiopharmaceutical candidates gain momentum on 28 May 2025, expanding possibilities in treatment of solid tumors and …
Several Phase 1 and Phase 2 trials report encouraging results this month, amplifying momentum in precision psychiatry, respiratory …
Recent clinical trials are opening new doors for breast cancer treatment, improving accessibility with telehealth and reporting encouraging …
New data from India suggest that Hillchol, an oral cholera vaccine by Bharat Biotech, is safe, effective and …